Thursday Sep 15, 2022
To boost or not to boost – Part 2
This episode continues our discussion on the new bivalent COVID boosters that target the original virus and also Omicron subvariants BA.4 and BA.5.
Guest speaker:
Azra Behlim, PharmD, MBA
Associate Vice President, Pharmacy Sourcing and Program Services
Vizient
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Clinical Operations and Quality
Vizient
Show Notes:
[00:30] Is the booster safe?
[00:48] Efficacy
[01:32] How long to wait after previous vaccine
[02:47] Whether or not to get flu vaccines
[05:58] Feasibility of using the booster as an initial vaccine in a series
[07:52] Novavax
[09:05] Nasal vaccines and mucosal immunity
Links | Resources:
To contact Modern Practice: modernpracticepodcast@vizientinc.com
FDA announcement on new vaccine boosters (8-31-22): Click here
Subscribe Today!